RGEN
RGEN
NASDAQ · Life Sciences Tools & Services

Repligen Corp

$163.90
+4.46 (+2.80%)
As of Aug 8, 1:17 AM ET ·
Day Range $159.44 — $164.97
52W Range $100.99 — $175.77

Performance

1D
1W
1M
3M
6M +14.15%
1Y +47.09%
YTD -0.27%
Open$159.44
Previous Close$159.44
Day High$164.97
Day Low$159.44
52W High$175.77
52W Low$100.99
Volume
Avg Volume1.35M
Market Cap9.16B
P/E Ratio220.50
EPS$0.73
SectorLife Sciences Tools & Services

Technical Indicators

Full analysis →
SMA 50 $157.63 Above
SMA 200 $139.06 Above
RSI (14) 28 Oversold
Trend Golden Cross Bullish

Analyst Ratings

Strong Buy
28 analysts
23 Buy 5 Hold 0 Sell
Price Target -62.1% upside
Current
$163.90
Target
$62.10
$40.44 $62.10 avg $74.58

Key Financials

FY 2026 FY 2025 FY 2024
Revenue 729.42M 749.66M 4.59B
Net Income 48.31M 44.68M 325.04M
Profit Margin 6.6% 6.3% 7.1%
EBITDA 132.31M 129.18M 499.02M
Free Cash Flow 285.62M
Rev Growth -2.7% -2.7% +1.3%
Debt/Equity 0.26 0.26 0.50

Life Sciences Tools & Services Peers

Symbol Name Price Change P/E Mkt Cap
TMO Thermo Fisher Scientific Inc $594.00 +2.41% 31.0 216.08B
DHR Danaher Corp $204.76 +2.39% 35.7 142.96B
A Agilent Technologies Inc $145.97 +3.28% 28.7 40.57B
IQV Iqvia Holdings Inc $238.70 +2.70% 28.4 39.03B
MTD Mettler-Toledo International $1,429.46 +0.58% 32.7 28.58B
WAT Waters Corp $406.86 +1.79% 87.4 39.24B

RGEN News

No news for RGEN yet

Quick Stats

Market Cap9.16B
P/E Ratio220.50
EPS$0.73
Volume
SectorLife Sciences Tools & Services